GMED
Globus Medical, Inc.Healthcare · $10.2B market cap
Verdict
Share price
$75.60
close of Oct 3, 2026
Fair value
$103.94
Sticker Price
Payback Price
$41.58
buy price
GMED is Undervalued: at $75.60 it trades 27% below its fair value of $103.94. Its buy price (Payback Price) is $41.58, 45% below today's price. Business quality is solid: 3 of 5 key numbers clear the 10% bar.
How we valued it
Free Cash Flow Growth. Free cash flow is growing faster than reported earnings, so we project free cash flow 10 years ahead instead.
Business quality
3 of 5 clear the 10% bar. What are the Big Five?
Follow GMED
Get notified when it reaches its buy price of $41.58. Free.
Create a free accountSuperinvestors
1 of the investors we track holds GMED. In Q2 2026, 1 sold out. Who we track
Moves in Q2 2026
Sold out: Lee Ainslie
Insider activity
Since Jul 27, 2026: no open-market purchases, 1 sale worth $2.2M and 2 other filings (stock awards, tax withholding and similar). Why purchases matter
Sales
Other filings
About Globus Medical, Inc.
Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral…
Medical - Devices
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works